Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation
Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation
复制标题
DOI:
10.1097/00007890-199709150-00015
复制
发表时间:
1997-09-15
期刊:
影响因子:
6.2
通讯作者:
Keenan, RJ
中科院分区:
文献类型:
--
作者:
Bauldoff, GS;Nunley, DR;Keenan, RJ
Background. In patients with cystic fibrosis (CF) who are awaiting lung transplant, prolonged exposure to systemic antibiotics has frequently led to airway colonization with resistant isolates of Pseudomonas. This resistance limits the arsenal of effective antimicrobials available for infections after the initiation of immunosuppression and has been considered a theoretical deterrent to lung transplantation.Methods. Twenty CF transplant candidates with ''pan-resistant'' Pseudomonas received maintenance antibiotic therapy with aerosolized colistin sodium (75 mg b.i.d.), and intravenous antibiotics were eliminated. Ten other CF candidates did not use colistin sodium. Sputum cultures and antibiotic sensitivities were followed every 3-6 weeks.Results. All 20 candidates (100%) who used aerosolized colistin sodium became colonized with sensitive isolates of Pseudomonas in an average of 45.1 +/- 20.2 days. In contrast, only 3 of 10 CF transplant candidates (30%) who did not use colistin sodium later became colonized with sensitive isolates. The mean time to spontaneous emergence of sensitive organisms was 144.6 +/- 48.0 days in candidates who did not use colistin sodium and was significantly longer than in the candidates who used colistin sodium (P=0.007). The occurrence of redeveloping sensitive isolates of Pseudomonas was significantly greater in the candidates who used colistin sodium (P